Auricular Acupressure Relieves Constipation for Patients With Heart Failure in Hospital
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05988502 |
Recruitment Status :
Completed
First Posted : August 14, 2023
Last Update Posted : August 16, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Heart Failure Auricular Acupressure Constipation Quality of Life Depression, Anxiety | Other: auricular acupressure | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 72 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | The participants were randomized into two groups by a research team not involved in the study intervention or data collection. The randomization process was accomplished through a computer-generated sequence of random numbers, and permuted block randomization was employed with four in each block. The random sequence of numbers was separately and sequentially stored in sealed, opaque envelopes that were opened in front of the participants in the predetermined order, which determined their group allocation.the auricular acupressure (AA) group was given auricular acupressure for two weeks and the control group received usual care for heart failure during the same study period. Data were collected consisted of three repeated measurement time points at baseline, Week 1, and Week 2. |
Masking: | Double (Participant, Outcomes Assessor) |
Masking Description: | The random sequence of numbers was separately and sequentially stored in sealed, opaque envelopes that were opened in front of the participants in the predetermined order, which determined their group.The participants do not know their own group, the researcher knows the participant's group and intervenes according to the participant's group, and the outcomes Assessor conducts the outcomes assessment without knowing the participant's group |
Primary Purpose: | Supportive Care |
Official Title: | Auricular Acupressure Relieves Constipation for Patients With Heart Failure in Hospital: a Randomised Controlled Trial |
Actual Study Start Date : | March 6, 2022 |
Actual Primary Completion Date : | October 30, 2022 |
Actual Study Completion Date : | October 30, 2022 |
Arm | Intervention/treatment |
---|---|
Experimental: auricular acupressure (AA) group
the auricular acupressure (AA) group was given auricular acupressure for two weeks
|
Other: auricular acupressure
The well-trained researcher nurse in this study was performed the AA intervention. First of all, the participant was instructed to find a comfortable position. Disinfect the ears using cotton with 75 % alcohol was then provided and followed by placed vaccaria seeds (Beijing, China) with an adhesive patch onto the unilateral each selected auricular acupoint (left ear first) Participants were pressed each acupoint by thumb and index finger for one minute, four times a day, five days a week, remove the taped seeds on the 6th day, and then replaced the opposite ear two days after. They were noted that they experienced various sensations while pressing, including numbness, swelling, mild pain, or warmth. Seeds were taped on the other side of the ear weekly for two weeks. Two TCM physicians verified the conduct of the AA protocol, which consisted of a selection of acupoints, length of stimulation time, finding location of acupoint, and procedure of practice. |
No Intervention: control group
all participants received the same routine care which was general heart failure care and medications for constipation therapy provided by the study hospital professionals. Prior to the study, every participant was assessed by the cardiologist and identified as being appropriate and safe.
|
- Change from Baseline constipation at 2 weeks by using the Bristolv Stool Form Scale [ Time Frame: baseline, Weeks 1 and 2 ]Outcomes were assessed by using the Bristolv Stool Form Scale. This scale categorized tools between type 1 (hard lumps) and type 7 (watery diaphragm). Type 1 was separate hard lump like nuts(hard to pass), type 2 was sausage-shaped but lumpy, type 3 was like a sausage but with cracks on its surface, type 4 was like a sausage or snake, smooth and soft, type 5 was soft blobs with clear-cut edges (passed easily), type 6 is fluffy pieces with ragged edges (a mushy stool), and type 7 was watery, no solid pieces (entirely liquid). Stool types were then classified based on the Rome III criteria as stool types 1 and 2 as constipation, types 3, 4, and 5 as normal stool form, and types 6 and 7 as diarrhea,
- Change from Baseline constipation at 2 weeks by using the Constipation Assessment Scale [ Time Frame: baseline, Weeks 1 and 2 ]Outcomes were assessed by using the Constipation Assessment Scale. The CAS comprised of 8 items, and each item used a 3-point Likert-type scale ranging 0~2, with a total score of 0 to 16. A higher score indicated severer constipation symptom.
- Change from Baseline constipation at 2 weeks by using the Visual Scale Analog for constipation [ Time Frame: baseline, Weeks 1 and 2 ]Outcomes were assessed by using the Visual Scale Analog for constipation. The VSAQ was used to measure the immediate severity of constipation, with a 10 cm straight line with 0 on the far left (0 score) and 10 cm (10 scores) on the far right. A score ≥ 3 indicated constipation, a higher score indicating severer constipation,
- Change from Baseline constipation at 2 weeks by using the Patient Assessment of Constipation Symptoms . [ Time Frame: baseline, Weeks 1 and 2 ]Outcomes were assessed by using the Patient Assessment of Constipation Symptoms .This scale comprised of 12 items with 3 subscales, including stool symptoms, rectal symptoms, and abdominal symptoms. Each item used a 5-point Likert-type scale ranging 0~4, with a total score of 0 to 48. A higher score indicated symptom severity.
- Change from Baseline Body constitution in Chinese Medicine at 2 weeks [ Time Frame: at baseline, Weeks 2 ]Outcomes were assessed by using the Constitution in Chinese Medicine Questionnaire. It consisted of 60 items and categorized into 9 subscales, including yang-deficient (7 items), yin-deficient (8 items), qi-deficient (8 items), phlegm-dampness (8 items), damp-heat (6 items), stagnant blood (7 items), inherited special (7 items), stagnant qi (7 items), and balanced (8 items). The items were on a 5-point Likert scale, with high scores indicating a higher likelihood of having the given body constitution. A threshold of 30 or higher points on a subscale was used to classify having that body constitution.
- Change from Baseline Anxiety at 2 weeks [ Time Frame: at baseline, Weeks 1 and 2 ]Outcomes were assessed by using the Beck Anxiety Inventory. This scale consisted of 21 items that used a 4-point Likert-type scale ranging 0~3, with a total score of 0 to 63. The normal score range was 0-16, 17-22 for mild anxiety, 23-30 for moderate anxiety , and 31-63 for severe anxiety.
- Change from Baseline Depression at 2 weeks [ Time Frame: at baseline, Weeks 1 and 2 ]Outcomes were assessed by using the Beck Depression Inventory II. This scale consisted of 21 items that used a 4-point Likert-type scale ranging 0~3, with a total score of 0 to 63. The normal score range was 0-16, 17-22 for mild depression, 23-30 for moderate depression, and 31-63 for severe depression.
- Patient Assessment of Constipation Quality of Life [ Time Frame: at baseline, Weeks 2 ]Outcomes were assessed by using the Patient Assessment of Constipation Quality of Life, constipation affecting in daily life. It comprised of 28 items with 4 subscales, including worries and concerns, physical discomfort, psychosocial discomfort, and satisfaction. Each item used a 5-point Likert-type scale ranging 0~4, with a total score of 0 to 112. A lower score indicated better quality of life.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 20 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- New York Heart Association (NYHA) functional classes I-III
- Constipation(had fewer than three bowel movements a week)
- Conscious clear and communicable
Exclusion Criteria:
- Other serious diseases
- Wounds or infections in both ears
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05988502
Taiwan | |
Far Eastern Memorial Hospital | |
New Taipei City, Taiwan, 220 |
Principal Investigator: | Yi-Ting Chen | Far Eastern Memorial Hospital |
Responsible Party: | Far Eastern Memorial Hospital |
ClinicalTrials.gov Identifier: | NCT05988502 |
Other Study ID Numbers: |
110269-F |
First Posted: | August 14, 2023 Key Record Dates |
Last Update Posted: | August 16, 2023 |
Last Verified: | July 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Anxiety auricular acupressure constipation |
heart failure quality of life Depression |
Heart Failure Constipation Depression Behavioral Symptoms |
Heart Diseases Cardiovascular Diseases Signs and Symptoms, Digestive |